208 related articles for article (PubMed ID: 33811067)
21. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
22. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
23. An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?
Kaufman G; d'Ovidio R; Kaldawy A; Assy B; Ullmann Y; Etzioni A; Paus R; Gilhar A
Exp Dermatol; 2010 Aug; 19(8):e347-9. PubMed ID: 20653774
[TBL] [Abstract][Full Text] [Related]
24. Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle.
Deng W; Zhang Y; Wang W; Song A; Mukama O; Huang J; Han X; Deng S; Lin Z; Habimana JDD; Huang R; Peng K; Ni B; Zhang S; Yan X; Li J; Wu LP; Li Z
Stem Cell Res Ther; 2021 Oct; 12(1):548. PubMed ID: 34674748
[TBL] [Abstract][Full Text] [Related]
25. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
27. Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma.
Shin JM; Choi DK; Sohn KC; Koh JW; Lee YH; Seo YJ; Kim CD; Lee JH; Lee Y
Sci Rep; 2018 Aug; 8(1):12518. PubMed ID: 30131581
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
Dai Z; Chen J; Chang Y; Christiano AM
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830087
[TBL] [Abstract][Full Text] [Related]
30. The potential of regulatory T cell-based therapies for alopecia areata.
Wan S; Xu W; Xie B; Guan C; Song X
Front Immunol; 2023; 14():1111547. PubMed ID: 37205097
[TBL] [Abstract][Full Text] [Related]
31. Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata.
McElwee KJ; Silva K; Beamer WG; King LE; Sundberg JP
Exp Dermatol; 2001 Dec; 10(6):420-9. PubMed ID: 11737261
[TBL] [Abstract][Full Text] [Related]
32. Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice.
Freyschmidt-Paul P; Seiter S; Zöller M; König A; Ziegler A; Sundberg JP; Happle R; Hoffmann R
J Invest Dermatol; 2000 Oct; 115(4):653-7. PubMed ID: 10998138
[TBL] [Abstract][Full Text] [Related]
33. Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes.
Hashimoto K; Yamada Y; Sekiguchi K; Matsuda S; Mori S; Matsumoto T
J Dermatol Sci; 2021 Jun; 102(3):177-183. PubMed ID: 33994063
[TBL] [Abstract][Full Text] [Related]
34. NLRP3 inflammasome activation contributes to development of alopecia areata in C3H/HeJ mice.
Hashimoto K; Yamada Y; Sekiguchi K; Mori S; Matsumoto T
Exp Dermatol; 2022 Feb; 31(2):133-142. PubMed ID: 34270818
[TBL] [Abstract][Full Text] [Related]
35. Alopecia areata in aging C3H/HeJ mice.
Sundberg JP; Cordy WR; King LE
J Invest Dermatol; 1994 Jun; 102(6):847-56. PubMed ID: 8006447
[TBL] [Abstract][Full Text] [Related]
36. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
[TBL] [Abstract][Full Text] [Related]
37. SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata.
Hao L; Nam KH; Lee GJ; Kim D; Shin JM; Lee Y; Kim CD; Kim SJ; Yun SK; Park BH; Park J
J Dermatol Sci; 2023 Jul; 111(1):2-9. PubMed ID: 37268558
[TBL] [Abstract][Full Text] [Related]
38. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice.
McElwee KJ; Niiyama S; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Hoffmann R
Exp Dermatol; 2003 Feb; 12(1):30-6. PubMed ID: 12631244
[TBL] [Abstract][Full Text] [Related]
39. Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata.
Dai Z; Sezin T; Chang Y; Lee EY; Wang EHC; Christiano AM
Front Immunol; 2022; 13():955038. PubMed ID: 36203601
[TBL] [Abstract][Full Text] [Related]
40. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
Freyschmidt-Paul P; Happle R; Hoffman R
J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
